Thailand Healthcare and Pharmaceuticals Sector Report 2016/2017

Thailand is the second-largest pharmaceutical market in South East Asia, with sales of THB 152.9bn in 2015. The pharmaceutical industry specialises in generic drug production and this is the largest segment on the market. Spending on health is significant – 6.5% of GDP in 2014 – and the share of private health spending in it is only 14%. The country is a popular health tourism destination, offering high-quality services at relatively low prices.

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Thailand . EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the healthcare and pharmaceutical sector in Thailand
• Access forecasts for growth in the sector
• View key data on healthcare spending and health insurance in Thailand
• Crystallise the forces both driving and restraining this sector in Thailand
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in Thailand
• Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).

See below for a complete table of report contents: